Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Using hyperbaric oxygen for autism treatment: A review and discussion of literature. Undersea Hyperb Med 2015;42(4):353-9

Date

09/26/2015

Pubmed ID

26403019

Scopus ID

2-s2.0-84938810471 (requires institutional sign-in at Scopus site)   4 Citations

Abstract

PURPOSE: To determine whether hyperbaric oxygen (HBO2) therapy should be used for the treatment of autism spectrum disorders (ASD).

METHODS: A literature search was performed on PubMed, Cochrane Library and DynaMed for studies evaluating the use of HBO2 for ASD treatment. The studies were then reviewed for the highest quality evidence.

RESULTS: The evidence is weak for the use of HBO2 in ASD, with only one, likely flawed, randomized control study showing treatment benefit.

CONCLUSIONS: HBO2 should not be recommended for ASD treatment until more conclusive favorable results and long-term outcomes are demonstrated from well-designed controlled trials.

Author List

Martin R, Srivastava T, Lee J, Raj N, Koth KA, Whelan HT

Author

Kathleen A. Koth DO Associate Professor in the Psychiatry and Behavioral Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Autistic Disorder
Cerebrovascular Circulation
Child
Child Development Disorders, Pervasive
Encephalitis
Humans
Hyperbaric Oxygenation